These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 17417063

  • 1. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response.
    Jabbi M, Kema IP, van der Pompe G, te Meerman GJ, Ormel J, den Boer JA.
    Psychiatr Genet; 2007 Jun; 17(3):183-93. PubMed ID: 17417063
    [Abstract] [Full Text] [Related]

  • 2. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA.
    Jabbi M, Korf J, Kema IP, Hartman C, van der Pompe G, Minderaa RB, Ormel J, den Boer JA.
    Mol Psychiatry; 2007 May; 12(5):483-90. PubMed ID: 17453062
    [Abstract] [Full Text] [Related]

  • 3. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients.
    Zumárraga M, Dávila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, González-Torres MA, Guimón J.
    Neurochem Int; 2010 May; 56(6-7):774-9. PubMed ID: 20206656
    [Abstract] [Full Text] [Related]

  • 4. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
    Huuhka K, Anttila S, Huuhka M, Hietala J, Huhtala H, Mononen N, Lehtimäki T, Leinonen E.
    Neurosci Lett; 2008 Dec 19; 448(1):79-83. PubMed ID: 18929622
    [Abstract] [Full Text] [Related]

  • 5. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.
    Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N.
    Rheumatol Int; 2003 May 19; 23(3):104-7. PubMed ID: 12739038
    [Abstract] [Full Text] [Related]

  • 6. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ, Chen TJ, Tsai SJ, Yu YW, Cheng CY, Hong CJ.
    Pharmacogenet Genomics; 2009 Oct 19; 19(10):735-41. PubMed ID: 19741570
    [Abstract] [Full Text] [Related]

  • 7. Genome survey for susceptibility loci for recurrent, early-onset major depression: results at 10cM resolution.
    Zubenko GS, Hughes HB, Stiffler JS, Zubenko WN, Kaplan BB.
    Am J Med Genet; 2002 May 08; 114(4):413-22. PubMed ID: 11992563
    [Abstract] [Full Text] [Related]

  • 8. COMT Val158Met moderation of stress-induced psychosis.
    Stefanis NC, Henquet C, Avramopoulos D, Smyrnis N, Evdokimidis I, Myin-Germeys I, Stefanis CN, Van Os J.
    Psychol Med; 2007 Nov 08; 37(11):1651-6. PubMed ID: 17640440
    [Abstract] [Full Text] [Related]

  • 9. An integrated approach to infer causal associations among gene expression, genotype variation, and disease.
    Lee E, Cho S, Kim K, Park T.
    Genomics; 2009 Oct 08; 94(4):269-77. PubMed ID: 19540336
    [Abstract] [Full Text] [Related]

  • 10. Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity and recovery.
    Alexander N, Osinsky R, Mueller E, Schmitz A, Guenthert S, Kuepper Y, Hennig J.
    Behav Brain Res; 2011 Jan 01; 216(1):53-8. PubMed ID: 20620172
    [Abstract] [Full Text] [Related]

  • 11. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK.
    Bipolar Disord; 2007 Jun 01; 9(4):370-6. PubMed ID: 17547583
    [Abstract] [Full Text] [Related]

  • 12. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior.
    Tochigi M, Suzuki K, Kato C, Otowa T, Hibino H, Umekage T, Kato N, Sasaki T.
    Pharmacogenet Genomics; 2007 Oct 01; 17(10):867-72. PubMed ID: 17885625
    [Abstract] [Full Text] [Related]

  • 13. The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study.
    Åberg E, Fandiño-Losada A, Sjöholm LK, Forsell Y, Lavebratt C.
    J Affect Disord; 2011 Mar 01; 129(1-3):158-66. PubMed ID: 20828831
    [Abstract] [Full Text] [Related]

  • 14. Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response.
    Tzang RF, Hong CJ, Liou YJ, Yu YW, Chen TJ, Tsai SJ.
    Neurosci Lett; 2008 Dec 05; 447(1):92-5. PubMed ID: 18838110
    [Abstract] [Full Text] [Related]

  • 15. Interaction of serotonergic and noradrenergic gene variants in panic disorder.
    Freitag CM, Domschke K, Rothe C, Lee YJ, Hohoff C, Gutknecht L, Sand P, Fimmers R, Lesch KP, Deckert J.
    Psychiatr Genet; 2006 Apr 05; 16(2):59-65. PubMed ID: 16538182
    [Abstract] [Full Text] [Related]

  • 16. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.
    Pharmacogenet Genomics; 2008 Sep 05; 18(9):815-21. PubMed ID: 18698234
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subtle gene-environment interactions driving paranoia in daily life.
    Simons CJ, Wichers M, Derom C, Thiery E, Myin-Germeys I, Krabbendam L, van Os J.
    Genes Brain Behav; 2009 Feb 05; 8(1):5-12. PubMed ID: 18721261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.